Cargando…

11-[1-(4-Meth­oxy­phen­yl)-4-oxo-3-phen­oxy­azetidin-2-yl]-14-methyl-12-oxa-8,14-diaza­tetra­cyclo­[8.3.3.0(1,10).0(2,7)]hexa­deca-2(7),3,5-triene-9,13-dione

In the title compound, C(30)H(27)N(3)O(6), the furan and pyrrolidine rings adopt envelope conformations (with C and N atoms as the flaps, respectively). The piperidine ring is in a distorted boat conformation. The β-lactam ring is planar [maximum deviation = 0.0044 (16) Å] and forms dihedral angles...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundaramoorthy, S., Rajesh, R., Raghunathan, R., Velmurugan, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393999/
https://www.ncbi.nlm.nih.gov/pubmed/22798864
http://dx.doi.org/10.1107/S160053681202733X
_version_ 1782237800244969472
author Sundaramoorthy, S.
Rajesh, R.
Raghunathan, R.
Velmurugan, D.
author_facet Sundaramoorthy, S.
Rajesh, R.
Raghunathan, R.
Velmurugan, D.
author_sort Sundaramoorthy, S.
collection PubMed
description In the title compound, C(30)H(27)N(3)O(6), the furan and pyrrolidine rings adopt envelope conformations (with C and N atoms as the flaps, respectively). The piperidine ring is in a distorted boat conformation. The β-lactam ring is planar [maximum deviation = 0.0044 (16) Å] and forms dihedral angles of 30.61 (9) and 85.51 (9)°, respectively, with the attached meth­oxy­phenyl and phen­oxy rings. The crystal packing is stabilized by N—H⋯O and C—H⋯O inter­actions forming R (2) (2)(8), R (2) (2)(20) and R (2) (2)(14) ring motifs. The crystal structure is further consolidated by weak C—H⋯π inter­actions.
format Online
Article
Text
id pubmed-3393999
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-33939992012-07-13 11-[1-(4-Meth­oxy­phen­yl)-4-oxo-3-phen­oxy­azetidin-2-yl]-14-methyl-12-oxa-8,14-diaza­tetra­cyclo­[8.3.3.0(1,10).0(2,7)]hexa­deca-2(7),3,5-triene-9,13-dione Sundaramoorthy, S. Rajesh, R. Raghunathan, R. Velmurugan, D. Acta Crystallogr Sect E Struct Rep Online Organic Papers In the title compound, C(30)H(27)N(3)O(6), the furan and pyrrolidine rings adopt envelope conformations (with C and N atoms as the flaps, respectively). The piperidine ring is in a distorted boat conformation. The β-lactam ring is planar [maximum deviation = 0.0044 (16) Å] and forms dihedral angles of 30.61 (9) and 85.51 (9)°, respectively, with the attached meth­oxy­phenyl and phen­oxy rings. The crystal packing is stabilized by N—H⋯O and C—H⋯O inter­actions forming R (2) (2)(8), R (2) (2)(20) and R (2) (2)(14) ring motifs. The crystal structure is further consolidated by weak C—H⋯π inter­actions. International Union of Crystallography 2012-06-23 /pmc/articles/PMC3393999/ /pubmed/22798864 http://dx.doi.org/10.1107/S160053681202733X Text en © Sundaramoorthy et al. 2012 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Organic Papers
Sundaramoorthy, S.
Rajesh, R.
Raghunathan, R.
Velmurugan, D.
11-[1-(4-Meth­oxy­phen­yl)-4-oxo-3-phen­oxy­azetidin-2-yl]-14-methyl-12-oxa-8,14-diaza­tetra­cyclo­[8.3.3.0(1,10).0(2,7)]hexa­deca-2(7),3,5-triene-9,13-dione
title 11-[1-(4-Meth­oxy­phen­yl)-4-oxo-3-phen­oxy­azetidin-2-yl]-14-methyl-12-oxa-8,14-diaza­tetra­cyclo­[8.3.3.0(1,10).0(2,7)]hexa­deca-2(7),3,5-triene-9,13-dione
title_full 11-[1-(4-Meth­oxy­phen­yl)-4-oxo-3-phen­oxy­azetidin-2-yl]-14-methyl-12-oxa-8,14-diaza­tetra­cyclo­[8.3.3.0(1,10).0(2,7)]hexa­deca-2(7),3,5-triene-9,13-dione
title_fullStr 11-[1-(4-Meth­oxy­phen­yl)-4-oxo-3-phen­oxy­azetidin-2-yl]-14-methyl-12-oxa-8,14-diaza­tetra­cyclo­[8.3.3.0(1,10).0(2,7)]hexa­deca-2(7),3,5-triene-9,13-dione
title_full_unstemmed 11-[1-(4-Meth­oxy­phen­yl)-4-oxo-3-phen­oxy­azetidin-2-yl]-14-methyl-12-oxa-8,14-diaza­tetra­cyclo­[8.3.3.0(1,10).0(2,7)]hexa­deca-2(7),3,5-triene-9,13-dione
title_short 11-[1-(4-Meth­oxy­phen­yl)-4-oxo-3-phen­oxy­azetidin-2-yl]-14-methyl-12-oxa-8,14-diaza­tetra­cyclo­[8.3.3.0(1,10).0(2,7)]hexa­deca-2(7),3,5-triene-9,13-dione
title_sort 11-[1-(4-meth­oxy­phen­yl)-4-oxo-3-phen­oxy­azetidin-2-yl]-14-methyl-12-oxa-8,14-diaza­tetra­cyclo­[8.3.3.0(1,10).0(2,7)]hexa­deca-2(7),3,5-triene-9,13-dione
topic Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393999/
https://www.ncbi.nlm.nih.gov/pubmed/22798864
http://dx.doi.org/10.1107/S160053681202733X
work_keys_str_mv AT sundaramoorthys 1114methoxyphenyl4oxo3phenoxyazetidin2yl14methyl12oxa814diazatetracyclo8330110027hexadeca2735triene913dione
AT rajeshr 1114methoxyphenyl4oxo3phenoxyazetidin2yl14methyl12oxa814diazatetracyclo8330110027hexadeca2735triene913dione
AT raghunathanr 1114methoxyphenyl4oxo3phenoxyazetidin2yl14methyl12oxa814diazatetracyclo8330110027hexadeca2735triene913dione
AT velmurugand 1114methoxyphenyl4oxo3phenoxyazetidin2yl14methyl12oxa814diazatetracyclo8330110027hexadeca2735triene913dione